Objective: To integrate the available data published on peripheral giant cell granuloma (PGCG) into a comprehensive analysis of its clinical/radiological features.
| Inclusion and exclusion criteria
Eligibility criteria included publications reporting cases of PGCG. The studies needed to contain enough clinical, radiological, and histological information to confirm the diagnosis. Randomized and controlled clinical trials, cohort studies, case-control studies, cross-sectional studies, case series, and case reports were included. Exclusion criteria were immunohistochemical studies, histomorphometric studies, radiological studies, genetic expression studies, histopathological studies, cytological studies, cell proliferation/apoptosis studies, in vitro studies, and review papers, unless any of these publication categories had reported any cases with enough clinical, radiological, and histological information.
Hybrid tumors containing parts of PGCG were not considered for this study, as they may behave differently from non-hybrid PGCG.
The definitions and criteria of the World Health Classification of Tumors-Head and Neck Tumors book 1 (last updated in 2017) were used to diagnose a lesion as PGCG. Other lesions or syndromic conditions presenting lesions with similar features, such as hyperparathyroidism, aneurismal bone cyst, cherubism, neurofibromatosis, Noonan syndrome, or cases with altered levels of parathyroid hormone, calcium, and phosphorus were excluded.
| Study selection
The titles and abstracts of all reports identified through the electronic searches were read independently by the authors. For studies appearing to meet the inclusion criteria, or for which there were insufficient data in the title and abstract to make a clear decision, the full report was obtained. Disagreements were resolved by discussion between the authors. The clinical and radiological aspects, as well as the histological description of the lesions reported by the publications, were thoroughly assessed by one of the authors (R.S.G.) of this study, an expert in oral pathology, to confirm the diagnosis of PGCG.
| Data extraction
The review authors independently extracted data using specially designed data extraction forms. Any disagreements were resolved by discussion. For each of the identified studies included, the following data were then extracted on a standard form, when 3 | RESULTS
| Literature search
The study selection process is summarized in Figure S1 were included in the review (see Appendix S1).
| Description of the studies and analyses
A total of 165 publications reporting 2824 PGCGs were included in the present review. Table 1 Table 3 shows the recurrence rate according to the some variables. Excision followed by curettage decreases the probability of recurrence by 85% in comparison with excision alone. Other factors seem to do not influence the probability of recurrence. 
| DISCUSSION
The aim of the present study was to integrate the available data published in the literature on PGCG into an updated comprehensive comparative analysis of their clinical features, as well as the frequency of recurrence. A review of pathological lesions is important because it provides information that can improve diagnostic accuracy, allowing pathologists and surgeons to make informed decisions and refine treatment plans to optimize clinical outcomes. [7] [8] [9] The present review observed that PGCGs were slightly more prevalent in women and more prevalent in mandibles, usually asymptomatic, and presenting erosion of the subjacent bone in almost one-third of cases. As the great majority of lesions were treated by excision, with or without curettage, it is difficult to compare success or relapse between the different modalities. The rate of recurrence of 10% shows that treatment is sometimes neglected by the professional, and curettage or peripheral osteotomy after excision seems to have a positive effect. Thus, excision with an additional therapy (curettage or osteotomy) should be the first choice of treatment.
There are few cases treated by sclerotherapy, but sometimes it does not represent definitive treatment. As the peripheral lesions are easily excised, we understand that sclerotherapy does not have the same utility as in central lesions.
Recurrences of PGCGs could be related to incomplete removal of the lesion. The lack of removal of the periosteum with the surgical excision could be related to a higher recurrence. 5 As this information was rarely reported in the publications reviewed, it is not possible to make a proper analysis. Still, Mighell et al 5 reported that histopathologically incompletely excised lesions from their study did not always recur, indicating that partial excision may be sufficient in some cases. It seems that due to the slight invasion of the tumor in the bone, especially when erosion of the underlying bone is present, remnants of the lesion may be left when only excision is performed, which may increase the chances of recurrence. 92% of the lesions that recurred in one study 4 exhibited transection of lesional tissue at the deep base of the specimen.
Genetic mutations are not exclusive for neoplasms, being reported in proliferative conditions, such as pyogenic granuloma. 10 Recently, mutations in cancer-related genes were reported in central giant cell lesions. 11 Although no driver genetic event in either central or peripheral giant cell lesions has been described, future studies should focus on the investigation of the molecular alterations in these lesions in recurrent and non-recurrent cases.
The results of our study have to be interpreted with caution because of its limitations. First, there is a difference in the number of cases being analyzed between Tables 1 and 3 , with far less cases in Table 3 . Most of the cases of PGCG described in the literature were reported in clinical series, and some of them contain hundreds of lesions, as the publication of Motamedi et al. 12 This kind of study does not usually inform the characteristics of each lesion separately, that is, one by one, but as a group. In that way, it is possible to use the information provided by clinical series to calculate, for example, the global recurrence rate, how many lesions were present in men and women and so on. However, it is not possible to use these data to calculate the effect size-in this case odds ratio-because there is no separate information of each variable (age, sex, location, etc)
for each lesion. Thus, there is no way to connect a reported recurrence with any of these factors. Therefore, only the lesions with detailed individual information-most of them reported in case F I G U R E 2 Topographical distribution of the known precise locations (n = 563) of peripheral giant cell granulomas. Cases involving multiple regions (or an entire quadrant) are indicated between arrows. Numbers at the top and bottom of the lines indicate cases involving both adjoining regions: anterior/premolar and premolar/molar. For the rest of the lesions (n = 2261), the location was the "maxilla" (n = 293), "mandible" (n = 385), "anterior maxilla" (n = 260), "posterior maxilla" (n = 236), "anterior mandible" (n = 370), "posterior mandible" (n = 441), and "not available" (n = 276) Significance of the difference of the recurrence rate between "excision alone" and "excision + curettage". Odds ratio of the recurrence probability of "excision + curettage" in relation to "excision alone". For the comparison or prevalence between "enucleation alone" and enucleation plus additional therapy ("+ curettage" and "+ peripheral osteotomy" considered together). Significance of the difference of the treatment prevalence between lesions of.
reports-were used for the calculation of the effect size. Second, all included studies were retrospective reports, which inherently result in errors, with incomplete records. Third, many of the published cases had a short follow-up, which could have led to an underestimation of the actual recurrence rate. Almost two-thirds of the lesions were followed up to only 1 year. However, it is hard to define what it would be considered a short follow-up period to evaluate the recurrence of these lesions.
| CONCLUSIONS
As surgical excision alone shows a considerable recurrence rate, excision followed by an additional therapy-curettage or peripheral osteotomy-should be the first choice of treatment of PGCG.
